Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,327Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Entresto

PharmaCompass

01

Brand Name : Entresto

Sacubitril/Valsartan

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Entresto

arrow
2024 ACI Convention
Not Confirmed

Sacubitril/Valsartan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 3,548

2020 Revenue in Millions : 2,497

Growth (%) : 42

blank

02

Brand Name : Entresto

Sacubitril/Valsartan

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Entresto

arrow
2024 ACI Convention
Not Confirmed

Sacubitril/Valsartan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 4,644

2021 Revenue in Millions : 3,548

Growth (%) : 31

blank

03

Brand Name : Entresto

Sacubitril/Valsartan

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Entresto

arrow
2024 ACI Convention
Not Confirmed

Sacubitril/Valsartan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 6,035

2022 Revenue in Millions : 4,644

Growth (%) : 30

blank